Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03639701 · ClinicalTrials.gov registry record · Phase 1
Treatment of TK2 Deficiency With Thymidine and Deoxycytidine
A Phase 1 study of Thymidine Kinase 2 Deficiency and Mitochondrial DNA Depletion Syndrome 2 Myopathic Type, sponsored by Columbia University.
- Active
- Registry status
- Phase 1
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT03639701 is a Phase 1 study of Thymidine Kinase 2 Deficiency and Mitochondrial DNA Depletion Syndrome 2 Myopathic Type that is active but no longer recruiting, run by Columbia University. The registered enrollment target is 23 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03639701, a Phase 1 study of Thymidine Kinase 2 Deficiency and Mitochondrial DNA Depletion Syndrome 2 Myopathic Type, is active but no longer recruiting, sponsored by Columbia University.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients with confirmed mitochondrial DNA depletion syndrome 2 (thymidine kinase 2 \[TK2\] deficiency) have reduced levels of nucleotides (deoxythymidine monophosphate and deoxycytidine monophosphate) for mitochondrial DNA synthesis. This results in mitochondrial DNA depletion syndrome (i.e less number of functional mitochondrial DNA). Patients with confirmed TK2 deficiency will be treated with open label deoxythymidine (dThd) and deoxycytidine (dCyt), which are nucleotide precursors, with the expectation that the cells could make additional mitochondrial DNA. This in turn may help reduce the clinical symptoms.
Conditions Studied
Interventions
- DRUG Thymidine
Study Locations (1)
New York
- Columbia University Irving Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2017-05-16 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03639701
The ClinicalTrials.gov registry entry for NCT03639701 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Thymidine Kinase 2 Deficiency appearing as the primary indexed condition, and to 1 intervention - of which Thymidine is the first listed.
NCT03639701 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03639701 about?
NCT03639701 is a clinical study titled "Treatment of TK2 Deficiency With Thymidine and Deoxycytidine". Patients with confirmed mitochondrial DNA depletion syndrome 2 (thymidine kinase 2 \[TK2\] deficiency) have reduced levels of nucleotides (deoxythymidine monophosphate and deoxycytidine monophosphate) for mitochondrial DNA synthesis. This results in mitochondrial DNA depletion syndrome (i.e less num...
What is the current status of trial NCT03639701?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 23 participants. The study started on 2017-05-16. Estimated completion is 2026-12-31.
What conditions does trial NCT03639701 study?
This clinical trial studies the following conditions: Thymidine Kinase 2 Deficiency, Mitochondrial DNA Depletion Syndrome 2 Myopathic Type.
What interventions are being tested in trial NCT03639701?
The interventions under investigation include: Thymidine (DRUG).
Who is sponsoring clinical trial NCT03639701?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03639701 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thymidine Kinase 2 Deficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Thymidine Kinase 2 Deficiency
All registered trials for this condition
Mitochondrial DNA Depletion Syndrome 2 Myopathic Type
All registered trials for this condition
New York
All trials with a study site in New York
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.